Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD) in Patients With Acute on Chronic Hepatitis (AOCH)

Trial Profile

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD) in Patients With Acute on Chronic Hepatitis (AOCH)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Dec 2013

At a glance

  • Drugs Extracorporeal hepatocyte-based therapy (Primary)
  • Indications Hepatitis; Liver failure
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Vital Therapies
  • Most Recent Events

    • 07 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top